Disclosure Of First-Time Adoption [Text Block]

STADA Arzneimittel AG - Filing #6743034

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	1,403 EUR	—	—	1.215.544 EUR	906,037 EUR	—	10,343 EUR	1.136.260 EUR	79,283 EUR	514,206 EUR	455,012 EUR	162,090 EUR	—	—	87,645 EUR	929,706 EUR	162,090 EUR	—	776,985 EUR	1,403 EUR	528,096 EUR	514,206 EUR	1.017.351 EUR	—	5,924 EUR	—	1.080.342 EUR	115,126 EUR	400,937 EUR	514,206 EUR	1.195.468 EUR	108,000 EUR	806,278 EUR	1,403 EUR	162,090 EUR
Comprehensive income	—	—	—	—	—	—	—	—	—	—	—	—	344,698 EUR	57,611 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit (loss)	—	16,871 EUR	246,939 EUR	—	—	246,939 EUR	—	—	—	—	—	—	263,810 EUR	181,899 EUR	—	—	—	167,314 EUR	—	—	—	—	—	14,585 EUR	—	167,314 EUR	—	—	—	—	—	—	—	—	—